Anna Mondino

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

Journal: Human gene therapy

Published: June 18, 2026

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.

Journal: Human gene therapy

Published: March 28, 2026

An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade.

An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade.

Journal: Theranostics

Published: January 10, 2026

Neoadjuvant ultrahypofractionated radiotherapy with simultaneous integrated boost for glioblastoma: study protocol for a phase I multicenter clinical trial.

Neoadjuvant ultrahypofractionated radiotherapy with simultaneous integrated boost for glioblastoma: study protocol for a phase I multicenter clinical trial.

Journal: BMC cancer

Published: October 27, 2025

The promyelocytic leukemia PML protein coordinates immune evasion in triple-negative breast cancer via independent and converging mechanisms.

The promyelocytic leukemia PML protein coordinates immune evasion in triple-negative breast cancer via independent and converging mechanisms.

Journal: Cell death and differentiation

Published: October 27, 2025

TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Journal: Nature communications

Published: April 15, 2025

Blockade of αvβ6 and αvβ8 integrins with a chromogranin A-derived peptide inhibits TGFβ activation in tumors and suppresses tumor growth.

Blockade of αvβ6 and αvβ8 integrins with a chromogranin A-derived peptide inhibits TGFβ activation in tumors and suppresses tumor growth.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 14, 2025

Highlighting recent achievements to advance more effective cancer immunotherapy.

Highlighting recent achievements to advance more effective cancer immunotherapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 21, 2024

A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities.

A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities.

Journal: Methods in cell biology

Published: November 08, 2024

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.

Journal: Oncoimmunology

Published: June 26, 2023

Pivotal role of the protein corona in the cell uptake of fluorinated nanoparticles with increased sensitivity for 19F-MR imaging.

Pivotal role of the protein corona in the cell uptake of fluorinated nanoparticles with increased sensitivity for 19F-MR imaging.

Journal: Nanoscale advances

Published: April 11, 2023

Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary Cancers.

Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary Cancers.

Journal: European urology oncology

Published: April 04, 2023

Showing 1-12 of 61

Last Updated: 09/26/2026